New Venture Funds Reporting Capital on November 9: 23 Filings, $166.8 Million, and a Life Sciences Fund in the Lead

Monday, November 9, 2026 was a lighter day for venture-tagged fund filings than the previous week, but it included a life sciences fund, a large co-investment vehicle and several small seed funds. In the AngelLinx export for filings dated November 9, we found 23 venture-tagged vehicles after removing duplicates by issuer, filing date and amount. Together they reported $166.8 million sold. The figures below are amounts reported at the filing date, not final fund sizes or targets, and a filing means a vehicle has sold interests to investors and not that it is writing cheques today.

The Ranked List

These are the largest venture-tagged filings of the day, ranked by reported amount.

• Windham Life Sciences Partners IV, L.P.: $58.6 million, Adam E. Fine named
• Juniper Co-Invest III, LP: $52.7 million, Griff Bohm named
• B Ventures Group LP: $12.6 million, Brian Abrams named
• FAFO Fund I LP: $10.1 million, Nantte Armand Kivinen named
• Industrial Capital Strategic Deterrence I, L.P.: $7.5 million, Blake Masters named
• Saga Ventures Mido, LP: $7.45 million, Max Altman named
• U.S. HMC Series Fund LP, Series X: $3.15 million
• Mento VC Fund II LLC: $3.0 million, Alexander Zhuravlev named
• Blumberg Capital Opportunity Fund (SN), L.P.: $2.99 million, David J. Blumberg named
• Mario Kart Fund, LP: $2.8 million, Griff Bohm named

The top two filings made up $111.4 million, or about two-thirds of the $166.8 million total.

What We Know About the Leaders

Windham Life Sciences Partners IV reported $58.6 million. A third-party database lists Adam Fine as an executive officer of the fund, and Windham Venture Partners, whose co-founder and chief executive is named Adam Fine, describes a focus on seed and early-stage medical device and digital health companies. We could not confirm that the two are formally linked, and we found no public statement on this fund's size, vintage or strategy. Treat it as a life sciences vehicle by name only.

Juniper Co-Invest III reported $52.7 million and carries our SPV or deal-by-deal tag. A co-investment vehicle usually pools money for one company next to a larger fund. Griff Bohm is also named on the Mario Kart Fund, which reported $2.8 million the same day, so the two filings look related to one sponsor, though we could not confirm what either holds.

Sector Mix: Mostly Generalist and Single-Deal

Of the 23 filings, 12 carry our generalist or unspecified tag, 8 carry the SPV or deal-by-deal tag, 2 are space and defence and 1 is biotech and life sciences. The thematic funds are rare. Windham was the only life sciences vehicle, and the two space and defence filings are discussed in our companion piece on space and defence funds. Our sector tags come from names and descriptions, so some may be wrong.

Size Bands

Two filings reported $50 million or more, eleven reported between $1 million and $50 million, six reported under $1 million and four reported zero. Three of the zeros are Altimeter Premier Growth IX, L.P., filed by Brad Gerstner, and the two Balerion Space Ventures Global Fund I vehicles. A zero means a new vehicle was registered before any amount was reported. It does not mean a failed raise, and we do not rank those.

What This Means for Founders

Do not treat a filing as a pledge to invest. Ask any manager how much of the fund is already committed, how many new companies they plan to back this year and what cheque size they write.

Match your round to the fund band. A manager with $2 million to $10 million of reported capital will usually write small cheques and suits pre-seed or seed. A vehicle with $50 million or more may lead larger rounds, but check whether it is a co-investment vehicle that can only follow a lead.

If an investor offers to invest through a co-investment vehicle or SPV, expect an additional entry on your cap table. Ask who signs for the vehicle and what information rights its backers have, and have it reviewed in the term sheet.

Prepare your data room before outreach. Founders who can answer due diligence questions quickly gain time with managers who have just sold new interests. Model dilution for a few round sizes and decide whether a SAFE or a priced round suits you.

For life sciences founders, the lesson is that dedicated funds are scarce. One biotech-tagged filing appeared in a day of 23, so build a list of specialist investors and approach them directly. Browse life sciences investors in the biotech investor directory.

What We Could Not Confirm

We did not confirm the final size, target or strategy of any vehicle in this list. Sector tags are classifications from names. Our export for this date covers one filing day, so a later update may add filings.

Key Takeaways

Twenty-three venture-tagged funds reported $166.8 million on November 9, led by Windham Life Sciences Partners IV at $58.6 million. Two filings made up about two-thirds of the total, and most vehicles were small generalist or single-deal pools. Ask each manager about deployment and cheque size before you pitch.

Browse the investor directory to find active investors, and explore active capital on AngelLinx @ angellinx.ai/register.

AngelLinx Intelligence | angellinx.ai